Business Description
INOVIQ Ltd is an Australian biotechnology company focused on improving how cancer and other serious diseases are detected and treated. The company develops non-invasive diagnostic tools, including a urine-based test for bladder cancer and a technology platform that uses exosomes ? tiny particles released by cells ? to identify disease markers in the body. Operating in both Australia and the United States, INOVIQ aims to give doctors better tools for early screening, diagnosis, and treatment decisions. Founded in 2016 and based in Notting Hill, Australia, the company was previously known as BARD1 Life Sciences Limited before rebranding in late 2021.
